Evidence map›Paper›PMID 40986319›Full record

ArticleThe Journal of experimental medicine2025

Type I IFN drives neutrophil swarming, impeding lung T cell-macrophage interactions and TB control.

William J Branchett, Evangelos Stavropoulos, Jessica Shields, Alaa Al-Dibouni, Marcos Cardoso, Ana Isabel Fernandes, Lúcia Moreira-Teixeira, Hubert Slawinski, Anna Mikolajczak, Angela Rodgers and 2 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Restricted MHC-II trafficking inbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Modulation of Ferroptosis During EarlybioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. HowVaccines · 2026
    Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

William J BranchettImmunoregulation and Infection Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0003-4353-4857
Evangelos StavropoulosImmunoregulation and Infection Laboratory, The Francis Crick Institute, London, UK.ORCID 0009-0006-2238-799X
Jessica ShieldsImmunoregulation and Infection Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0003-4246-9862
Alaa Al-DibouniImmunoregulation and Infection Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0001-7913-2038
Marcos CardosoImmunoregulation Laboratory, i3S , Porto, Portugal.ORCID 0000-0003-0150-7359
Ana Isabel FernandesImmunoregulation Laboratory, i3S , Porto, Portugal.ORCID 0000-0002-5703-4303
Lúcia Moreira-TeixeiraImmunoregulation and Infection Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-4817-8196
Hubert SlawinskiGenomics Science Technology Platform, The Francis Crick Institute , London, UK.ORCID 0000-0002-8996-8477
Anna MikolajczakExperimental Histopathology Science Technology Platform, The Francis Crick Institute , London, UK.ORCID 0009-0002-0603-6867
Angela RodgersHost-Pathogen Interactions in Tuberculosis Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-2981-6455
Margarida SaraivaImmunoregulation Laboratory, i3S , Porto, Portugal.ORCID 0000-0002-8180-1293
Anne O'GarraImmunoregulation and Infection Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0001-9845-6134

Funding

Cancer Research UK FC001126Francis Crick InstituteFundação para a Ciência e a Tecnologia, Portugal 2020.05949.BDLa Caixa Foundation HR21-00415UK Medical Research CouncilWellcome Investigator WT 215628/Z/19/ZWellcome Trust FC001126
6 · The paper itself

Abstract

The early immune mechanisms determining Mycobacterium tuberculosis infection outcome are unclear. Using bulk and scRNA-seq over the first weeks of infection, we describe an unexpected, higher early pulmonary type I IFN response in relatively resistant C57BL/6 as compared with highly TB-susceptible C3HeB/FeJ mice. C57BL/6 mice showed pronounced early monocyte-derived macrophage (MDM) accumulation and extensive CD4+ T cell-MDM interactions in lung lesions, accompanied by high expression of T cell-attractant chemokines by MDMs. Conversely, lesions in C3HeB/FeJ mice were dominated by neutrophils with high expression of pro-inflammatory chemokines, from which CD4+ T cells were spatially segregated. Early type I IFN signaling blockade reduced bacterial load and neutrophil swarming within early TB lesions while increasing CD4+ T cell numbers in both C57BL/6 and C3HeB/FeJ mice, with later more pronounced effects on bacterial load in C3HeB/FeJ mice. These data suggest that early type I IFN signaling during M. tuberculosis infection favors neutrophil accumulation and limits CD4+ T cell infiltration into developing lesions.

Indexed as

CD4-Positive T-LymphocytesInterferon Type IMacrophages, AlveolarNeutrophilsTuberculosis, PulmonaryAnimalsBacterial LoadCell CompetitionDisease Models, AnimalFemaleLungMaleMiceMice, Inbred C57BLMycobacterium tuberculosisSignal TransductionInterferon Type I

Identifiers

PMID40986319
PMCPMC12456410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.